CollPlant Biotechnologies Ltd.

US$3.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CLGNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (161.98%)
Biotechnology
Beta (5Y) 0.57
PE TTM —
TSR TTM (81.62%)
Mkt cap US$7.507M
ROIC (73.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.39
10.59%
(94.72%)
Hold 9|5|10|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.09
0.09
0.10
16.00%
8.21%
15.78%
22.87%
Revenue$M
0.362
0.364
0.363
0.364
8.77%
5.36%
3.80%
4.61%
Peers (US$7.507M)
Cap (US$)
PE
9.333M
—
7.483M
—
Capital
TTM
5Y
10Y
Leveragex
0.138
0.167
0.154
EBIT/Intx
0.886
0.105
0.100
Own earn%
(44.45)
(134.58)
(131.91)
Sh yield%
22.31
51.24
50.15
Owners
Insiders/Inst%
6.04
80.43
Short interest%
5.72
SBC / revenue%
5.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
4–15
$1 testx
—
Incr. ROIC%
5